Skip to main content
OpenTrials
Completed

NCT Number: NCT01947595

Individualized Lifestyle Intervention in Subjects With Prediabetes

The purpose of this prospective randomized multicenter intervention study is to determine whether in the prevention of Diabetes an intensified lifestyle intervention is superior to a conventional lifestyle intervention in high risk non-Responder subjects. Further, the intensive phenotyping to determine subgroups with an increased risk for diabetes enables an individualized prevention and therapy of type 2 diabetes mellitus.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Deutsches Institut für Ernährungsforschung / Charité Berlin, Berlin, Germany

Loading trial locations.

About this study

The study start with an intensive phenotyping at baseline (initial examination) to determine subjects with prediabetes. These high risk non-Responder are randomized in two arms (intensified vs normal lifestyle intervention)with equal number of subjects (n=250). The results are compared with each other at the end of the study.

The low risk Responder are randomized in two arms (normal vs. once lifestyle intervention = control group) with equal number of subjects (n=250).

After the screening at baseline the 12 month lifestyle intervention starts for lifestyle intervention groups. The different therapy groups are formed as described before. The subjects with intensified lifestyle intervention get 16 consultations, the subjects with normal lifestyle intervention get 8 consultations, the subjects of the control group get one consultation to learn more about a healthier lifestyle. During the whole study there is a continuous supervision from physician and nutritional advisers and the subjects have to document a nutrition and an exercise protocol as well as subjective measurements. At baseline, after 24 weeks and at follow up 1, 2 and 3 years later there is an elaborate metabolic characterization of all subjects (also the Responder groups) a 75 g venous oral glucose tolerance test (OGTT) as well as an analysis of the distribution of body fat confirmed by MR-Imaging and proton magnetic resonance spectroscopy by 3 T whole body imager.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • impaired fasting glucose (IFG)
  • fasting blood glucose 99-126 mg/dl

and/or

  • impaired glucose tolerance (IGT)
  • 75 g OGTT 120 minutes: 139-200 mg/dl

Exclusion criteria

  • current pregnancy or breastfeeding
  • BMI > 45 kg/m²
  • Diabetes mellitus Typ 1 or 2
  • serious disease e.g symptomatic coronary heart disease
  • serious symptomatic malignant disease (weight loss > 10% within the last 6 month)
  • severe liver or kidney disease ( an increase in transaminases > 3 times than the upper limit of the standardized range, GFR < 50 ml/min/1,73m²)
  • systemic infection (CRP > 1 mg/dl)
  • severe mental illness
  • drug abuse
  • treatment with steroids
  • potentially incompliant subjects
  • exclusion criteria for magnetic resonance tomography
  • any kind of metal in or on the body:
  • cardiac pacemakers
  • prosthetic heart valves
  • metal prosthesis
  • magnetic implanted metallic parts
  • contraceptive coil
  • metal fragments/ grenade shrapnel
  • fixed braces
  • acupuncture needles
  • insulin pump
  • intraport etc.
  • Field strength > 3 Tesla further tattoos, permanent make-up
  • persons with limited thermosensory or heightened sensitivity to heating
  • persons where cardiovascular disease cannot be ruled out by examination
  • persons with heightened sensitivity to loud noise or diseases of the ear
  • used closed whole body scanner: claustrophobia

Additional for spirometry

  • acute coronary syndrome
  • higher cardiac arrhythmia
  • decompensated heart failure
  • acute carditis
  • pulmonary embolism
  • acute deep leg vein thrombosis ( phlebothrombosis)
  • hyperthyroidism (TSH)
  • hypokalemia

Treatment and study plan

intensified lifestyle intervention

Behavioral
  • physical activity 6 hours per week, 50% guided activity
  • recorded by an accelerometer (Aipermotion 440)
  • 16 sessions per year with a lifestyle advisor
  • nutritional advice (target weight: 5% less, if BMI > 25kg/m², less than 30% fat per caloric intake, less than 10% fatty acids per caloric intake, more than 15 g fibre per 1000 kcl)

normal lifestyle intervention

Behavioral
  • physical activity 3 hours per week
  • recorded by an accelerometer (Aipermotion 440)
  • 8 sessions per year with a lifestyle advisor
  • nutritional advice (target weight: 5% less, if BMI > 25kg/m², less than 30% fat per caloric intake, less than 10% fatty acids per caloric intake, more than 15 g fibre per 1000 kcl)

Single lifestyle advice

Behavioral
  • Single Health care advice and lifestyle advice (30 minutes) at the beginning
  • recommend the individual target weight (5% less, if BMI 25> kg/m²)

Primary outcomes

  1. postprandial glycaemia (2h plasma glucose level of the 75 g oral glucose tolerance test (OGTT))

    Time frame: one year

Secondary outcomes

  1. insulin sensitivity confirmed by 75 g oral glucose tolerance test (OGTT)

    Time frame: one year

    insulin resistance is calculated as follows:

    • Insulinogenic index (IGI) = (I30 - I0) / (G30 - G0)
    • ISIest= 10000/²√ ((G0 x I0) x ((G0+G30+G60+G90+G120)/5) x ((I0+I30+I60+I90+I120)/5))
  2. insulin secretion confirmed by 75 g oral glucose tolerance test (OGTT)

    Time frame: one year

    insulin resistance is calculated as follows:

    • Insulinogenic index (IGI) = (I30 - I0) / (G30 - G0)
    • ISIest= 10000/²√ ((G0 x I0) x ((G0+G30+G60+G90+G120)/5) x ((I0+I30+I60+I90+I120)/5))
  3. distribution of body fat confirmed by MR-Imaging and proton magnetic resonance spectroscopy by 3 T whole body imager

    Time frame: one year

Other outcomes

  1. metabolic and genetic characterization to determine the risk of type 2 diabetes confirmed by case history, clinical examination, venous blood sampling, DNA isolation, standardised questionnaires, bio-electric impedance analysis (BIA)and ergospirometry

    Time frame: one year

  2. metabolic and genetic characterization to determine the non-response to lifestyle intervention confirmed by case history, clinical examination, venous blood sampling, DNA isolation, standardised questionnaires,BIA, ergospirometry

    Time frame: one year

Sponsors and collaborators

Lead sponsor

University Hospital Tuebingen

Other

Collaborators

  • Endocrinology and Metabolic Diseases, Charité Berlin
  • German Diabetes-Center, Leibniz-Institut in Düsseldorf
  • German Institute of Human Nutrition
  • Ludwig-Maximilians - University of Munich
  • University Hospital Carl Gustav Carus
  • University Hospital Heidelberg

Registry information

Official study title

Prediabetes Lifestyle Intervention Study

Acronym: PLIS

Important dates

Study start
2012
Primary completion
2017
Study completion
2017
First posted
Sep 20, 2013
Registry last updated
Aug 23, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.